Keyphrases
Bipolar Disorder
100%
Cerebrospinal Fluid
100%
Longitudinal Case
100%
Synaptic Markers
100%
Biomarker Changes
100%
Synaptic Proteins
40%
1-year Follow-up
20%
Protein Biomarkers
20%
β-synuclein
20%
Affective Episodes
10%
Healthy Controls
10%
Protein Level
10%
Dementia Risk
10%
First-ever
10%
Alzheimer's Disease
10%
Cognitive Impairment
10%
Change from Baseline
10%
Mass Spectrometry
10%
14-3-3 Protein
10%
Neurobiological Basis
10%
Cerebrospinal Fluid Biomarkers
10%
Release Mechanism
10%
Biomarker Concentration
10%
Synaptic Dysfunction
10%
Cerebrospinal Fluid Protein
10%
2-complex
10%
Euthymia
10%
Mood Episode
10%
Beta-gamma
10%
Neuronal Pentraxin 1
10%
PEBP1
10%
Multiple Reaction Monitoring
10%
Syntaxin-1
10%
Microflow Liquid Chromatography
10%
GDP Dissociation Inhibitor
10%
Complexin 2
10%
Neuronal Pentraxin Receptor
10%
Syntaxin 7
10%
NPTX2
10%
γ-synuclein
10%
Biochemistry, Genetics and Molecular Biology
Case-Control Study
100%
Liquid
100%
Pentraxin
40%
Beta-Synuclein
40%
Eicosanoid Receptor
20%
Binding Protein
20%
Synapsin I
20%
14-3-3 Protein
20%
Liquid Chromatography
20%
Phosphatidylethanolamine
20%
Protein Family
20%
Protein Cerebrospinal Fluid Level
20%
Syntaxin
20%
Complexin
20%
Gamma-Synuclein
20%
Neuroscience
Bipolar Disorder
100%
Pentraxin
20%
Beta Synuclein
20%
Eicosanoid Receptor
10%
Alzheimer's Disease
10%
Cognitive Disorders
10%
Synapsin I
10%
Protein Family
10%
14-3-3 Protein
10%
Syntaxin
10%
Phosphatidylethanolamine Binding Protein
10%
Guanine Nucleotide Dissociation Inhibitor
10%
Gamma Synuclein
10%